Invention Grant
- Patent Title: Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
-
Application No.: US17739669Application Date: 2022-05-09
-
Publication No.: US11932664B2Publication Date: 2024-03-19
- Inventor: Barbara Slusher , Rana Rais , Marcela Krecmerova , Tomas Tichy , Pavel Majer , Andrej Jancarik
- Applicant: THE JOHNS HOPKINS UNIVERSITY , INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR v.v.i.
- Applicant Address: US MD Baltimore
- Assignee: THE JOHNS HOPKINS UNIVERSTY,INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR V.V.I.
- Current Assignee: THE JOHNS HOPKINS UNIVERSTY,INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR V.V.I.
- Current Assignee Address: US MD Baltimore; CZ Prague
- Agency: Casimir Jones, SC
- Agent Jeffrey W. Childers
- The original application number of the division: US15968074 2018.05.01
- Main IPC: C07F9/6558
- IPC: C07F9/6558 ; C07F9/38 ; C07F9/40 ; C07F9/44
Abstract:
Methods and compounds are disclosed for treating a disease or condition by inhibiting PSMA (Prostate Specific Membrane Antigen) using prodrugs of 2-PMPA.
Public/Granted literature
- US20230115651A1 PRODRUGS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR Public/Granted day:2023-04-13
Information query
